| Autor: |
Marandino L; Laura Marandino, MD, and Daniele Raggi, MD, Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Department of Medical Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy; and Massimo Di Maio, MD, Department of Oncology, University of Turin, at Ordine Mauriziano Hospital, Torino, Italy., Raggi D; Laura Marandino, MD, and Daniele Raggi, MD, Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Department of Medical Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy; and Massimo Di Maio, MD, Department of Oncology, University of Turin, at Ordine Mauriziano Hospital, Torino, Italy., Necchi A; Laura Marandino, MD, and Daniele Raggi, MD, Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Department of Medical Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy; and Massimo Di Maio, MD, Department of Oncology, University of Turin, at Ordine Mauriziano Hospital, Torino, Italy., Di Maio M; Laura Marandino, MD, and Daniele Raggi, MD, Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Department of Medical Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy; and Massimo Di Maio, MD, Department of Oncology, University of Turin, at Ordine Mauriziano Hospital, Torino, Italy. |
| Abstrakt: |
Competing Interests: Laura MarandinoResearch Funding: AstraZeneca Andrea NecchiEmployment: BayerStock and Other Ownership Interests: BayerHonoraria: Roche, Merck, AstraZeneca, Janssen, Foundation Medicine, Bristol Myers SquibbConsulting or Advisory Role: Merck Sharp & Dohme, Roche, Bayer, AstraZeneca, Clovis Oncology, Janssen, Incyte, Seattle Genetics/Astellas, Bristol Myers Squibb, Rainier Therapeutics, GlaxoSmithKline, FerringResearch Funding: Merck Sharp & Dohme (Inst), AstraZeneca (Inst), Ipsen, Seattle Genetics (Inst)Travel, Accommodations, Expenses: Roche, Merck Sharp & Dohme, AstraZeneca, Janssen, Rainier TherapeuticsOther Relationship: Bayer Massimo Di MaioHonoraria: Pfizer, Takeda, AstraZeneca, Janssen, Eisai, Novartis, Roche, Astellas Pharma, MSD OncologyConsulting or Advisory Role: AstraZeneca, Pfizer, Takeda, Janssen, Eisai, Novartis, Roche, MSD Oncology, AmgenResearch Funding: Tesaro (Inst), GlaxoSmithKline (Inst)No other potential conflicts of interest were reported. |
